Hub ยท Peptide Quality & Verification
Peptide TFA salt: what trifluoroacetate is and how it is measured
A peptide TFA salt is a peptide that carries trifluoroacetate (TFA) as its counterion. Trifluoroacetate is the negative ion of trifluoroacetic acid, a chemical used to cleave a peptide from its synthesis resin and in HPLC purification. So synthetic peptides are often obtained as TFA salts. The counterion is measured by its own tests. An HPLC purity figure does not show it.
01What it isContents
Table salt is a pair. Sodium and chloride sit together, and the crystal is neither one alone. A peptide can be a pair too. The peptide carries charge, and a small ion of the opposite charge sits beside it. That partner is the counterion. For many synthetic peptides, the counterion is trifluoroacetate.
This page is part of the peptide quality and verification hub. It explains what a TFA salt is, why it turns up, and how the counterion is measured. It also explains why a purity number cannot name it. How HPLC purity is measured for peptides covers the purity figure itself. The page is research reference material, for research use only, and it makes no claim about the salt form of any Form Laboratories lot.
Guidethe peptide quality and verification hubHow research peptides are tested and verified: purity methods, certificates of analysis, batch traceability, and what each document can and cannot tell you.
GuideHow HPLC purity is measured for peptides
Key facts
| What it is | A peptide paired with trifluoroacetate (TFA), the negative ion of trifluoroacetic acid, as its counterion |
|---|---|
| Why it is common | Solid-phase peptide synthesis (SPPS) uses trifluoroacetic acid as a cleavage agent and as an ion-pairing reagent in purification (Erckes et al., 2025) |
| Methods used to measure it in the 2025 study | Fourier-transform infrared spectroscopy (FT-IR), fluorine-19 nuclear magnetic resonance (19F-NMR) and HPLC with an evaporative light-scattering detector (ELSD) |
| Amount in one reference material | Nearly 25% by mass in an angiotensin II candidate reference material, measured by 19F quantitative NMR (Melanson et al., 2018) |
| Exchange to another counterion | In the 2025 study, TFA was exchanged for chloride by freeze-drying from hydrochloric acid, with no impact on peptide purity observed |
| What the EMA guideline says | The type of counter ion should be defined and its amount controlled. Acetate is usual, and trifluoroacetate or chloride are also possible. The guideline covers medicinal products. |
| HPLC purity shows | Not the salt form |
| Results shown for Form Laboratories lots | None on this page |
| Use | Research reference material. Not for human or animal use |
What is a peptide TFA salt?
A peptide TFA salt is a peptide that is paired with trifluoroacetate, a small negative ion. Trifluoroacetate is what trifluoroacetic acid (TFA) becomes once it gives up a hydrogen ion. A peptide carries electric charge at some sites. The ion of opposite charge that balances it is called the counterion. The European Medicines Agency (EMA) guideline on synthetic peptides asks that the counterion be named, and that the report say whether it is present in a stoichiometric or non-stoichiometric ratio. Stoichiometric means a fixed whole-number ratio. If there is no counterion, the guideline asks for the free base to be stated.
The guideline says the type of counterion can affect the biological and physicochemical properties of the peptide. For synthetic peptides, it says acetate is usually used, but other counterions are possible, for example trifluoroacetate or chloride.
The guideline is written for medicinal products. It is not a rule for research products.
Why do synthetic peptides often carry TFA?
Synthetic peptides often carry TFA because making and purifying them uses trifluoroacetic acid. The 2025 study states that solid-phase peptide synthesis (SPPS) relies heavily on TFA as a cleavage agent, which frees the finished peptide from the solid resin it was built on. Purification relies on TFA as an ion-pairing reagent in HPLC, which is an additive that helps the peptide separate cleanly on the column. The authors state that this results in peptides being obtained as TFA salts. They also state that TFA has excellent properties for peptide production.
The same paper says that numerous studies point to a negative impact of TFA salts in biological assays. In its own liposome assay, the salt form and the peptide sequence both changed the measured membrane permeability. That finding is from one laboratory model with the peptides the authors chose. It is not a finding about any product.
The authors also report that the amount of counterion depends on the peptide's sequence, especially its positive charges. That is one reason the amount has to be measured for each peptide.
How are the counterion identity and amount measured?
The counterion is measured with its own tests, apart from the purity test. The 2025 study detected and quantified residual TFA with three methods: FT-IR, 19F-NMR and HPLC with an evaporative light-scattering detector. FT-IR reads how a sample absorbs infrared light. 19F-NMR reads the fluorine atoms in TFA. The authors report that all three methods were validated according to International Council for Harmonisation (ICH) guidelines. The 2018 reference-material paper used a validated fluorine-19 quantitative NMR method and found nearly 25% TFA by mass in one angiotensin II material.
The EMA guideline's list of techniques names liquid chromatography and ion chromatography for the identity of potential counterions. Its list of tests for an active substance has counter-ion identity and content, and residual ion content (TFA), as separate lines from purity.
The guideline also says the type of counterion should be defined and its amount controlled in the specification with a justified upper limit. That is a rule for medicinal products.
Why does an HPLC purity figure not show the salt form?
An HPLC purity figure is a share of detected peptide signal, so it does not name the counterion. The 2025 study shows the gap. The authors exchanged the TFA counterion for chloride by freeze-drying the peptides from hydrochloric acid. They report that no impact on peptide purity was observed at any acid concentration tested. The salt form changed and the purity did not. Purity by ultraviolet detection, as set out in the HPLC purity article, reads peptide peaks. The counterion was found with other tools.
The word HPLC does not decide what is measured. The same 2025 study used HPLC with an evaporative light-scattering detector to quantify TFA. That is a different detector from the ultraviolet detector behind a purity percentage.
The counterion also adds weight. In the angiotensin II reference material, it was nearly 25% by mass. Net peptide content explains how that weight changes the share of the powder that is peptide.
GuideHPLC purity article
GuideNet peptide contentNet peptide content is the share of a freeze-dried peptide's mass that is the peptide itself. How amino acid analysis, nitrogen analysis and mass balance measure it, and why it differs from HPLC purity.
Evidence limits
What has research not shown about peptide TFA salts?
The sources read for this page do not show how much TFA any commercial research peptide carries. The 2025 paper is a laboratory study of selected synthetic peptides and a liposome model. The 2018 paper measures one reference material. The EMA guideline is written for medicinal products, where it says acetate is usually used as the counterion. None of the three tests a commercial research lot. This page makes no statement about the salt form of any Form Laboratories lot.
The sources also do not say that a TFA salt is unsuitable for every purpose. The 2025 authors conclude that counterion quantification and specification matter in assays with synthetic peptides. Research-use-only material is not a medicine and is not for human or animal use.
Comparison
A reading checklist. It shows which test answers which question about the counterion. This is a general sketch, not a report from any real lot.
| Question | What HPLC purity shows | What answers it |
|---|---|---|
| Which counterion is present? | Nothing | A counterion identity test, such as liquid or ion chromatography (EMA guideline) |
| How much counterion is there? | Nothing | FT-IR, 19F-NMR or HPLC with an evaporative light-scattering detector (2025 study) |
| Did swapping the counterion change the purity? | The share of peptide signal, which stayed the same in the 2025 study | HPLC-UV purity measurements before and after exchange; counterion tests confirm the exchange |
| How much of the powder is peptide? | Nothing: an area percentage is not a weight | A content assay, plus water and counterion tests |
FAQ
What is a TFA salt in peptides?
A TFA salt is a peptide paired with trifluoroacetate, the negative ion of trifluoroacetic acid. The trifluoroacetate is the counterion. It balances the charge on the peptide.
Why do synthetic peptides contain TFA?
Solid-phase peptide synthesis uses trifluoroacetic acid as a cleavage agent, and peptide purification uses it as an ion-pairing reagent. A 2025 study states that this results in peptides being obtained as TFA salts.
Does 99% HPLC purity mean a peptide has no TFA?
No. An HPLC purity percentage is a share of detected peptide signal. It does not name the counterion or give its amount. In a 2025 study, swapping TFA for chloride left the measured peptide purity unchanged.
How is TFA measured in a peptide?
A 2025 study measured it with FT-IR, 19F-NMR and HPLC with an evaporative light-scattering detector. A 2018 reference-material paper used fluorine-19 quantitative NMR. The EMA guideline also lists liquid and ion chromatography for counterion identity.
Can TFA be exchanged for another counterion?
A 2025 study exchanged TFA for chloride by freeze-drying the peptides from hydrochloric acid and reported no impact on peptide purity. That is a laboratory method from one study. This page does not give a procedure.
Which counterion does the EMA guideline expect?
The EMA guideline on synthetic peptides says acetate is usually used as the counterion for medicinal use. It names trifluoroacetate and chloride as other possibilities and asks that the type be defined. The guideline covers medicinal products, not research products.
More in this hub
GuidePeptide Quality & VerificationHow research peptides are tested and verified: purity methods, certificates of analysis, batch traceability, and what each document can and cannot tell you.
GuideWhich peptide company is the most trusted?What regulator letters, batch tests and business records can show about peptide companies. Learn why company size cannot settle trust.
GuideHow to read a certificate of analysis (COA)What a certificate of analysis shows: its fields, purpose and layout, how it differs from a safety data sheet, what purity and identity numbers prove, and where the paperwork stops.
GuideHow to check a peptide certificate of analysis is genuineA field-by-field checklist for a peptide certificate of analysis: match the batch, confirm the laboratory, read the test scope, and see what each check can and cannot show.
GuideHow to check an Australian peptide supplier is legitimateTen checks for an Australian research peptide supplier: business identity, contact details, batch documents, test scope, payment records, handling and regulatory warnings.
GuideWhat research grade actually meansResearch grade is a catalogue phrase, not a published standard. What named grades like ACS and USP are, and what For Research Use Only does not mean.
GuideWhat a batch or lot number lets a researcher verifyA batch or lot number identifies one production run. What that code lets a researcher check, what it ties together, and where its verifying power stops.
GuideCJC-1295 with DAC vs without DAC: what is the difference?CJC-1295 with DAC and without DAC are two different peptides. Side-by-side sequence, half-life literature and registry numbers, and what modified GRF(1-29) means.
GuideSelank vs Semax: are they the same peptide?Selank and Semax are two different seven-amino-acid peptides that share a Pro-Gly-Pro ending. A position-by-position sequence table, origins, what studies say about which is better, DSIP, and the limits of comparing studies.
GuideIs NAD+ a peptide?NAD+ is a coenzyme made of two nucleotides, not a peptide. What the PubChem, ChEBI and wwPDB records show about its structure.
GuideHow mass spectrometry confirms peptide identityHow mass spectrometry confirms peptide identity: what a matching mass shows, how fragmentation reads the sequence, and why identical masses call for a second test.
GuideHow HPLC purity is measured for peptides
GuideEndotoxin, sterility and purity: three different testsWhat an endotoxin test, a sterility test and a purity test each measure, and which of the three the 14 lab reports on file at Form Laboratories document.
GuideBioburden vs endotoxin testing: what each one measuresBioburden testing counts living microorganisms. Endotoxin testing looks for a bacterial cell-wall molecule. Why one cannot stand in for the other, with ISO 11737-1 and FDA guidance cited.
GuideNet peptide content: what it is and how it is measuredNet peptide content is the share of a freeze-dried peptide's mass that is the peptide itself. How amino acid analysis, nitrogen analysis and mass balance measure it, and why it differs from HPLC purity.
GuideTypes of peptide impurities: sequence-related, degradation and non-peptideThe main categories of impurity in a synthetic peptide: sequence-related, degradation products and non-peptide material, and why different tests look for different categories. Cited to the EMA guideline.
GuideTB-500 vs thymosin beta-4: is TB-500 the same molecule?TB-500 and thymosin beta-4 are not the same molecule in the papers that define them: a full-length protein against a short acetylated fragment, compared side by side.
GuideWhat does a peptide cleavage predictor measure?What peptide cleavage predictors estimate from an amino acid sequence, what cut-site scores mean, and why a computer prediction needs separate lab evidence.
GuideWhat is peptide mass fingerprinting, and what can it identify?Peptide mass, mass-to-charge ratio and mass fingerprinting explained: what a database match can identify, why sequence matters, and what purity needs.
Citations
2 sourcesErckes V et al. Pharmaceuticals (Basel). 2025;18(8):1163.
doi:10.3390/ph18081163- Sourcedoi:10.3390/ph18081163
Melanson JE et al. Analytical and Bioanalytical Chemistry. 2018;410(26):6719-6731.
doi:10.1007/s00216-018-1272-7
Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.
